Digital healthcare revolution? Big data? How could Real World have improved the handling of the Covid-19 pandemic? In a nutshell, what is the contribution that information technology can make to the Health System? These are just some of the many questions to which Roche Italia has sought answers by initiating a dialogue with many of the players in the system: citizens and patients, doctors, scientists, institutions and technical experts. The campaign “Roche Now, big data united for health“Which, with the launch of the talk of the same name, aims to be a guide for all citizens interested in understanding how the analysis of an enormous amount of health data can radically change the world of healthcare and improve the health of citizens: this revolution is already in place.
“At Roche we believe that a health system that starts from data analysis to arrive at the personalization of care has the potential to improve the health conditions of citizens through targeted therapies, promoting cutting-edge research and with the ultimate aim of helping sustainability of the Health System. This is why we are committed to integrating the data deriving from the so-called Real World, or rather from clinical practical experience, to complement our research, also through collaborations with the other companies of the Group, such as the Diagnostics division, Foundation Medicine and FlatironHeatlh. We can proudly say that we are the only reality in the health sector that embraces the entire path of the patient and that thanks to the integration of genomic, clinical, economic-organizational data, it is able to offer solutions that include services, drugs and tests. innovative diagnostics “, he has declared Maurizio de Cicco, president and CEO of Roche Italia (pictured), presenting the campaign. “However, we have before us several challenges on which we need to work starting from the technological one, passing through the normative one and finally also and above all the cultural one. Because it is only thanks to citizens more confident in science, far-sighted institutions and politicians, a scientific community focused on patient needs and an industry that focuses on innovation that we will be able to build the healthcare of the future together. If not now, when?”.
During the virtual event for the presentation of the project “Roche Now, big data united for health“, The first cycle of digital talk conducted by the scientist Ennio Tasciotti was launched, which is developed through five video pills aimed at promoting greater awareness on issues such as Real World Data, Real World Evidence, FSE (Electronic Health Record), analyzing them from the point of view of the actors involved: from citizens to doctors, from institutions to technical experts in the sector and the media, with particular attention to current events. An efficient ecosystem of health data has in fact often been cited as a key success factor in the response to Covid-19, but the pandemic has also made more evident the numerous barriers that still limit the use and sharing of data. Many countries, in fact, including Italy, are characterized by a limited ability to collect, analyze and share high quality data, with consequent negative impacts on the effectiveness and efficiency of the system. In the case of Italy, the extreme heterogeneity of approach at the regional level (in terms of rules, procedures and customs), represents a further limitation to the opportunities deriving from an integrated analysis of health data.
“The evolution of medicine is experiencing a strange paradox, there is a widespread perception that the use of innovative tools such as big data makes it very complicated, but in reality artificial intelligence applied to research and medicine greatly simplifies the life of us scientists, but also of patients “, Tasciotti said. “In fact, the more complex the knowledge, tools and techniques developed, the more precise the responses relating to a diagnostic and therapeutic path can be. The use of big data and artificial intelligence will allow us to put at the service of patients the discoveries gained in all fields of science to improve the quality of life and the well-being of the community “.
For Vincenzo Valentini, Deputy Scientific Director of the Gemelli Irccs Polyclinic, “now it is up to the Government to pilot this transition to an increasingly digital-based medicine which represents an unavoidable challenge, full of opportunities and complexity but which can be an answer to guarantee a 360 ° sustainability of the system “.